GLEN ALLEN, Va., May 31, 2012 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., the manufacturer of Anatabloc® and a subsidiary of Star Scientific, Inc. CIGX, wishes to extend its congratulations to Fred Couples for being named 2013 U.S. Presidents Cup Captain. Couples, who became a spokesperson and brand ambassador for Anatabloc® in early 2012, was named the U.S. Captain by PGA Tour Commissioner, Tim Finchem, on Tuesday at the Memorial Tournament. The 2013 Presidents Cup will be held at Muirfield Village Golf Club in Dublin, Ohio, and this will be the third time Couples has served as Captain of the U.S. team. Previously, Couples led the U.S. golf teams to victories in San Francisco (2009) and in Australia (2011). 

(Photo: http://photos.prnewswire.com/prnh/20120531/PH16315)

(Photo: http://photos.prnewswire.com/prnh/20110830/PH59627)

(Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO)

Last week, Rock Creek reported on the retail expansion of Anatabloc® with GNC corporate stores.  In that press release, the company noted that on June 1, 2012, GNC will begin displaying a poster of Fred Couples in the front window of its corporate stores in all fifty states, as well as in the District of Columbia and Puerto Rico. Also, Rock Creek is preparing a national television commercial featuring Fred Couples that it anticipates will begin airing this summer.

Additionally, as referenced in the company's recent 10-Q filing, Star Scientific's reply to the petition for certiorari to the Supreme Court filed by R.J. Reynolds Tobacco Company, Inc. was due May 29, 2012. Consistent with the schedule established for briefing at the Supreme Court, the company's reply brief was timely filed Tuesday afternoon.

-------------------------------------------------------------------------------------------------

Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials, the challenges inherent in new product development initiatives, including the continued development and market acceptance of our nutraceutical and low-TSNA tobacco products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, including with respect to our nutraceutical and low-TSNA tobacco products, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our annual report on Form 10-K for the fiscal year ended December 31, 2011. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.

About Star Scientific

Star Scientific, Inc. is a technology-oriented company with a mission to promote maintenance of a healthy metabolism, as well as to reduce the harm associated with the use of tobacco at every level. Over the last several years, through its wholly owned subsidiary, Rock Creek Pharmaceuticals, Star Scientific has been engaged in the manufacturing, sale, and marketing of two nutraceutical dietary supplements, and the development of other nutraceuticals and pharmaceuticals. The company also has continued to pursue the development, implementation, and licensing of the technology behind its proprietary StarCured® tobacco curing process, which substantially prevents the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the tobacco-specific nitrosamines, or TSNAs and related low-TSNA dissolvable tobacco products. Rock Creek Pharmaceuticals has scientific and research offices in Gloucester, MA, and a regulatory office in Washington, DC. Star Scientific has a Corporate and Sales Office in Glen Allen, VA, an Executive, Scientific & Regulatory Affairs office in Bethesda, MD, and a manufacturing facility in Chase City, VA.

Web: anatabloc.com l Facebook: www.facebook.com/Anatabloc 

Contact:
Talhia T. Tuck
Vice President, Communications and Investor Relations
Star Scientific, Inc.
(301) 654-8300
ttuck@starscientific.com

SOURCE Star Scientific, Inc.